5. Conclusions
asthma
ASTHMA
In summary, type 2 asthma comprises a spectrum of heterogeneity that includes patients with and without elevated blood neutrophils. Treatment with dupilumab resulted in consistent improvements in lung function in patients with uncontrolled, moderate-to-severe asthma across the type 2 spectrum, irrespective of mixed heterogeneity as described by blood neutrophil levels. Comparable responses were observed in patients with blood eosinophils ≥ 300 cells/